5-7878066-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002454.3(MTRR):​c.524C>T​(p.Ser175Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.348 in 1,613,402 control chromosomes in the GnomAD database, including 100,433 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S175P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.32 ( 7888 hom., cov: 30)
Exomes 𝑓: 0.35 ( 92545 hom. )

Consequence

MTRR
NM_002454.3 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:10

Conservation

PhyloP100: -2.35

Publications

133 publications found
Variant links:
Genes affected
MTRR (HGNC:7473): (5-methyltetrahydrofolate-homocysteine methyltransferase reductase) This gene encodes a member of the ferredoxin-NADP(+) reductase (FNR) family of electron transferases. This protein functions in the synthesis of methionine by regenerating methionine synthase to a functional state. Because methionine synthesis requires methyl-group transfer by a folate donor, activity of the encoded enzyme is important for folate metabolism and cellular methylation. Mutations in this gene can cause homocystinuria-megaloblastic anemia, cbl E type. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Dec 2015]
MTRR Gene-Disease associations (from GenCC):
  • methylcobalamin deficiency type cblE
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0014089942).
BP6
Variant 5-7878066-C-T is Benign according to our data. Variant chr5-7878066-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 138304.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.362 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTRRNM_002454.3 linkc.524C>T p.Ser175Leu missense_variant Exon 5 of 15 ENST00000440940.7 NP_002445.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTRRENST00000440940.7 linkc.524C>T p.Ser175Leu missense_variant Exon 5 of 15 1 NM_002454.3 ENSP00000402510.2

Frequencies

GnomAD3 genomes
AF:
0.316
AC:
47805
AN:
151460
Hom.:
7871
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.265
Gnomad AMI
AF:
0.364
Gnomad AMR
AF:
0.241
Gnomad ASJ
AF:
0.369
Gnomad EAS
AF:
0.150
Gnomad SAS
AF:
0.376
Gnomad FIN
AF:
0.328
Gnomad MID
AF:
0.452
Gnomad NFE
AF:
0.366
Gnomad OTH
AF:
0.315
GnomAD2 exomes
AF:
0.311
AC:
78080
AN:
251244
AF XY:
0.320
show subpopulations
Gnomad AFR exome
AF:
0.263
Gnomad AMR exome
AF:
0.167
Gnomad ASJ exome
AF:
0.366
Gnomad EAS exome
AF:
0.158
Gnomad FIN exome
AF:
0.317
Gnomad NFE exome
AF:
0.364
Gnomad OTH exome
AF:
0.345
GnomAD4 exome
AF:
0.351
AC:
512993
AN:
1461824
Hom.:
92545
Cov.:
61
AF XY:
0.353
AC XY:
256369
AN XY:
727202
show subpopulations
African (AFR)
AF:
0.269
AC:
9002
AN:
33480
American (AMR)
AF:
0.176
AC:
7851
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.363
AC:
9493
AN:
26132
East Asian (EAS)
AF:
0.123
AC:
4886
AN:
39700
South Asian (SAS)
AF:
0.364
AC:
31403
AN:
86258
European-Finnish (FIN)
AF:
0.323
AC:
17276
AN:
53410
Middle Eastern (MID)
AF:
0.398
AC:
2292
AN:
5766
European-Non Finnish (NFE)
AF:
0.369
AC:
409778
AN:
1111964
Other (OTH)
AF:
0.348
AC:
21012
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
20629
41258
61888
82517
103146
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12754
25508
38262
51016
63770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.316
AC:
47854
AN:
151578
Hom.:
7888
Cov.:
30
AF XY:
0.313
AC XY:
23148
AN XY:
74012
show subpopulations
African (AFR)
AF:
0.265
AC:
10970
AN:
41342
American (AMR)
AF:
0.240
AC:
3659
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.369
AC:
1278
AN:
3460
East Asian (EAS)
AF:
0.150
AC:
767
AN:
5114
South Asian (SAS)
AF:
0.377
AC:
1799
AN:
4776
European-Finnish (FIN)
AF:
0.328
AC:
3428
AN:
10448
Middle Eastern (MID)
AF:
0.455
AC:
133
AN:
292
European-Non Finnish (NFE)
AF:
0.366
AC:
24822
AN:
67876
Other (OTH)
AF:
0.317
AC:
666
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1584
3169
4753
6338
7922
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
492
984
1476
1968
2460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.347
Hom.:
40447
Bravo
AF:
0.304
TwinsUK
AF:
0.373
AC:
1384
ALSPAC
AF:
0.365
AC:
1407
ESP6500AA
AF:
0.266
AC:
1172
ESP6500EA
AF:
0.360
AC:
3097
ExAC
AF:
0.315
AC:
38271
Asia WGS
AF:
0.293
AC:
1017
AN:
3478
EpiCase
AF:
0.366
EpiControl
AF:
0.369

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Nov 11, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 26, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Methylcobalamin deficiency type cblE Benign:4
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 19, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Gastrointestinal stromal tumor Uncertain:1
-
Department of Pharmacy and Biotechnology, University of Bologna
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:case-control

- -

Disorders of Intracellular Cobalamin Metabolism Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.0060
DANN
Benign
0.69
Eigen
Benign
-2.0
Eigen_PC
Benign
-2.1
FATHMM_MKL
Benign
0.033
N
LIST_S2
Benign
0.23
T;T
MetaRNN
Benign
0.0014
T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
-1.2
N;.
PhyloP100
-2.4
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-0.66
N;N
REVEL
Benign
0.022
Sift
Benign
0.33
T;T
Sift4G
Benign
0.40
T;T
Vest4
0.026
MPC
0.043
ClinPred
0.019
T
GERP RS
-11
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.017
gMVP
0.24
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1532268; hg19: chr5-7878179; COSMIC: COSV52941765; COSMIC: COSV52941765; API